{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T03:05:14Z","timestamp":1772593514080,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1038\/s41416-018-0183-x","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T12:32:08Z","timestamp":1532003528000},"page":"546-550","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission"],"prefix":"10.1038","volume":"119","author":[{"given":"Eliza A","family":"Hawkes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ortis","family":"Estacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis J","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gilbertson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"183_CR1","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/S0140-6736(13)60313-X","volume":"381","author":"D Cunningham","year":"2013","unstructured":"Cunningham, D. et al. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. Lancet 381, 1817\u20131826 (2013).","journal-title":"Lancet"},{"key":"183_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMc1609333","volume":"375","author":"P Johnson","year":"2016","unstructured":"Johnson, P., Trotman, J. & Federico, M. Interim PET-CT scan in advanced Hodgkin\u2019s lymphoma. N. Engl. J. Med. 375, 999\u2013100 (2016).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 2","key":"183_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hon.2437_63","volume":"35","author":"M Gleeson","year":"2017","unstructured":"Gleeson, M., Peckitt, C., To, Y. M., & Edwards, L. CHOP versus GEM-P in the first-line treatment of t-cell lymphoma (ptcl): initial results of the UK NCRI phase II randomised chemo-t trial. Haematol. Oncol. 35(Suppl. 2), 75\u201376 (2017).","journal-title":"Haematol. Oncol."},{"key":"183_CR4","unstructured":"National Comprehensive Cancer Network: The NCCN Non-Hodgkin's Lymphomas Clinical Practice Guidelines in Oncology (Version 2.2015): \n                    http:\/\/www.nccn.org"},{"key":"183_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1002\/ajh.23688","volume":"89","author":"TC El-Galaly","year":"2014","unstructured":"El-Galaly, T. C. et al. Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. Am. J. Hematol. 89, 575\u2013580 (2014).","journal-title":"Am. J. Hematol."},{"key":"183_CR6","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","volume":"32","author":"CA Thompson","year":"2014","unstructured":"Thompson, C. A. et al. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J. Clin. Oncol. 32, 3506\u20133512 (2014).","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 3","key":"183_CR7","doi-asserted-by":"publisher","first-page":"iii70","DOI":"10.1093\/annonc\/mdu181","volume":"25","author":"DA Eichenauer","year":"2014","unstructured":"Eichenauer, D. A. et al. Hodgkin\u2019s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25(Suppl. 3), iii70\u2013iii75 (2014).","journal-title":"Ann. Oncol."},{"issue":"Suppl. 2","key":"183_CR8","first-page":"102","volume":"8","author":"AD Zelenetz","year":"2001","unstructured":"Zelenetz, A. D. & Hoppe, R. T. Panel NN-HsLPG. NCCN: Non-Hodgkin\u2019s lymphoma. Cancer Control 8(Suppl. 2), 102\u2013113 (2001).","journal-title":"Cancer Control"},{"issue":"Suppl. 5","key":"183_CR9","doi-asserted-by":"publisher","first-page":"v116","DOI":"10.1093\/annonc\/mdv304","volume":"26","author":"H Tilly","year":"2015","unstructured":"Tilly, H. et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 26(Suppl. 5), v116\u2013v125 (2015).","journal-title":"Ann. Oncol."},{"key":"183_CR10","unstructured":"National Comprehensive Cancer Network: The NCCN Hodgkin Lymphoma Clinical Practice Guidelines in Oncology (Version 2.2015): \n                    http:\/\/www.nccn.org"},{"key":"183_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3109\/10428194.2014.949258","volume":"56","author":"X Wei","year":"2015","unstructured":"Wei, X. et al. Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma. Leuk. Lymphoma 56, 1261\u20131265 (2015).","journal-title":"Leuk. Lymphoma"},{"key":"183_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.leukres.2013.12.005","volume":"38","author":"L Yan-Li","year":"2014","unstructured":"Yan-Li, L., Kang-Sheng, G., Yue-Yin, P., Yang, J. & Zhi-Min, Z. The lower peripheral blood lymphocyte\/monocyte ratio assessed during routine follow-up after standard first-line chemotherapy is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Leuk. Res. 38, 323\u2013328 (2014).","journal-title":"Leuk. Res."},{"key":"183_CR13","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/leu.2010.108","volume":"24","author":"LF Porrata","year":"2010","unstructured":"Porrata, L. F. et al. Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Leukemia 24, 1343\u20131349 (2010).","journal-title":"Leukemia"},{"key":"183_CR14","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.lungcan.2016.08.002","volume":"100","author":"JM Bauml","year":"2016","unstructured":"Bauml, J. M. et al. Scan-associated distress in lung cancer: quantifying the impact of \u201cscanxiety\u201d. Lung Cancer 100, 110\u2013113 (2016).","journal-title":"Lung Cancer"},{"key":"183_CR15","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1093\/annonc\/mdq215","volume":"21","author":"CA Thompson","year":"2010","unstructured":"Thompson, C. A. et al. Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors. Ann. Oncol. 21, 2262\u20132266 (2010).","journal-title":"Ann. Oncol."},{"key":"183_CR16","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/annonc\/mds606","volume":"24","author":"A Bestawros","year":"2013","unstructured":"Bestawros, A., Foltz, L., Srour, N., Savage, K. J. & Connors, J. M. Patients\u2019 and physicians\u2019 roles in detecting recurrent Hodgkin lymphoma following complete remission. Ann. Oncol. 24, 1359\u20131363 (2013).","journal-title":"Ann. Oncol."},{"issue":"1","key":"183_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/bjh.14745","volume":"182","author":"Beth Chasty","year":"2017","unstructured":"Chasty B. et al. Lack of effectiveness of routine clinic and blood test-based follow-up for diffuse large B cell lymphoma. Br. J. Haematol. \n                    https:\/\/doi.org\/10.1111\/bjh.14745\n                    \n                   (2017).","journal-title":"British Journal of Haematology"},{"key":"183_CR18","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3109\/10428194.2012.679360","volume":"53","author":"D El-Sharkawi","year":"2012","unstructured":"El-Sharkawi, D. et al. Elevated lactate dehydrogenase levels detected during routine follow-up do not predict relapse in patients with diffuse large B-cell lymphoma who achieve complete remission after primary treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone-like immunochemotherapy. Leuk. Lymphoma 53, 1949\u20131952 (2012).","journal-title":"Leuk. Lymphoma"},{"key":"183_CR19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1159\/000353127","volume":"130","author":"J Hong","year":"2013","unstructured":"Hong, J. et al. Prognostic role of serum lactate dehydrogenase beyond initial diagnosis: a retrospective analysis of patients with diffuse large B cell lymphoma. Acta Haematol. 130, 305\u2013311 (2013).","journal-title":"Acta Haematol."},{"key":"183_CR20","doi-asserted-by":"publisher","first-page":"361","DOI":"10.7326\/0003-4819-114-5-361","volume":"114","author":"M Henry-Amar","year":"1991","unstructured":"Henry-Amar, M. et al. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group. Ann. Intern. Med. 114, 361\u2013365 (1991).","journal-title":"Ann. Intern. Med."},{"key":"183_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1200\/JCO.1997.15.3.1123","volume":"15","author":"MJ Torrey","year":"1997","unstructured":"Torrey, M. J., Poen, J. C. & Hoppe, R. T. Detection of relapse in early-stage Hodgkin\u2019s disease: role of routine follow-up studies. J. Clin. Oncol. 15, 1123\u20131130 (1997).","journal-title":"J. Clin. Oncol."},{"key":"183_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1136\/bmj.314.7077.343a","volume":"314","author":"JA Radford","year":"1997","unstructured":"Radford, J. A., Eardley, A., Woodman, C. & Crowther, D. Follow up policy after treatment for Hodgkin\u2019s disease: too many clinic visits and routine tests? A review of hospital records. BMJ 314, 343\u2013346 (1997).","journal-title":"BMJ"},{"key":"183_CR23","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1200\/JCO.1991.9.7.1196","volume":"9","author":"JC Weeks","year":"1991","unstructured":"Weeks, J. C., Yeap, B. Y., Canellos, G. P. & Shipp, M. A. Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J. Clin. Oncol. 9, 1196\u20131203 (1991).","journal-title":"J. Clin. Oncol."},{"key":"183_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijrobp.2015.01.039","volume":"92","author":"SM Hiniker","year":"2015","unstructured":"Hiniker, S. M. et al. Value of surveillance studies for patients with stage I to II diffuse large B-cell lymphoma in the rituximab era. Int. J. Radiat. Oncol. Biol. Phys. 92, 99\u2013106 (2015).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"183_CR25","first-page":"189","volume":"35","author":"BM William","year":"2013","unstructured":"William, B. M. et al. The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma. Rev. Bras. Hematol. Hemoter. 35, 189\u2013191 (2013).","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"183_CR26","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/leu.2011.112","volume":"25","author":"RA Wilcox","year":"2011","unstructured":"Wilcox, R. A. et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia 25, 1502\u20131509 (2011).","journal-title":"Leukemia"},{"key":"183_CR27","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3324\/haematol.2011.050138","volume":"97","author":"LF Porrata","year":"2012","unstructured":"Porrata, L. F. et al. Peripheral blood lymphocyte\/monocyte ratio at diagnosis and survival in classical Hodgkin\u2019s lymphoma. Haematologica 97, 262\u2013269 (2012).","journal-title":"Haematologica"},{"key":"183_CR28","first-page":"1481","volume":"91","author":"EC Moser","year":"2006","unstructured":"Moser, E. C. et al. Risk of second cancer after treatment of aggressive non-Hodgkin\u2019s lymphoma; an EORTC cohort study. Haematologica 91, 1481\u20131488 (2006).","journal-title":"Haematologica"},{"key":"183_CR29","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.3324\/haematol.12918","volume":"93","author":"S Sacchi","year":"2008","unstructured":"Sacchi, S. et al. Second malignancies after treatment of diffuse large B-cell non-Hodgkin\u2019s lymphoma: a GISL cohort study. Haematologica 93, 1335\u20131342 (2008).","journal-title":"Haematologica"},{"key":"183_CR30","doi-asserted-by":"publisher","first-page":"e2011065","DOI":"10.4084\/mjhid.2011.065","volume":"3","author":"A Bari","year":"2011","unstructured":"Bari, A. et al. Therapy-related myeloid neoplasm in non-Hodgkin lymphoma survivors. Mediterr. J. Hematol. Infect. Dis. 3, e2011065 (2011).","journal-title":"Mediterr. J. Hematol. Infect. Dis."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0183-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-018-0183-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:50Z","timestamp":1684616570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-018-0183-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1038\/s41416-018-0183-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"16 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the local institutional review boards. Austin Health Human Research Ethics Committee, reference number LNR\/15\/AUSTIN\/432. Eastern Health Human Research Ethics Committee, reference number LR117\/2015","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Materials, data and associated protocols are available from the corresponding author on reasonable request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Note"}}]}}